| Title |
Inactivation of PP2A by a recurrent mutation drives resistance to MEK inhibitors
|
|---|---|
| Published in |
Oncogene, September 2019
|
| DOI | 10.1038/s41388-019-1012-2 |
| Pubmed ID | |
| Authors |
Caitlin M. O’Connor, Daniel Leonard, Danica Wiredja, Rita A. Avelar, Zhizhi Wang, Daniela Schlatzer, Benjamin Bryson, Eesha Tokala, Sarah E. Taylor, Aditya Upadhyay, Jaya Sangodkar, Anne-Claude Gingras, Jukka Westermarck, Wenqing Xu, Analisa DiFeo, David L. Brautigan, Shozeb Haider, Mark Jackson, Goutham Narla |
X Demographics
The data shown below were collected from the profiles of 28 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 13 | 46% |
| Canada | 1 | 4% |
| Finland | 1 | 4% |
| Germany | 1 | 4% |
| United Kingdom | 1 | 4% |
| Unknown | 11 | 39% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 16 | 57% |
| Scientists | 12 | 43% |
Mendeley readers
The data shown below were compiled from readership statistics for 60 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 60 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 13 | 22% |
| Researcher | 6 | 10% |
| Student > Bachelor | 6 | 10% |
| Student > Master | 5 | 8% |
| Professor > Associate Professor | 3 | 5% |
| Other | 7 | 12% |
| Unknown | 20 | 33% |
| Readers by discipline | Count | As % |
|---|---|---|
| Biochemistry, Genetics and Molecular Biology | 25 | 42% |
| Pharmacology, Toxicology and Pharmaceutical Science | 4 | 7% |
| Chemistry | 4 | 7% |
| Medicine and Dentistry | 4 | 7% |
| Agricultural and Biological Sciences | 2 | 3% |
| Other | 4 | 7% |
| Unknown | 17 | 28% |
Attention Score in Context
This research output has an Altmetric Attention Score of 20. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 June 2020.
All research outputs
#1,845,703
of 24,998,746 outputs
Outputs from Oncogene
#356
of 11,044 outputs
Outputs of similar age
#38,341
of 349,460 outputs
Outputs of similar age from Oncogene
#5
of 145 outputs
Altmetric has tracked 24,998,746 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 92nd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 11,044 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.4. This one has done particularly well, scoring higher than 96% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 349,460 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 89% of its contemporaries.
We're also able to compare this research output to 145 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 97% of its contemporaries.